Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-03-26 @ 2:51 PM
Study NCT ID:
NCT00578292
Status:
TERMINATED
Last Update Posted:
2020-05-01
First Post:
2007-12-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
Sponsor:
Baylor College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-19
First Submit QC Date:
None
Study First Post Date:
2007-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-03
Results First Submit QC Date:
None
Results First Post Date:
2020-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-30
Last Update Post Date:
2020-05-01
Last Update Post Date Type:
ACTUAL